_edited_edi.png){kind=small}
AI in Healthcare How to Vet Vendors Before You Buy
EHFS Disclaimer: This content is provided for educational and informational purposes only and should not be construed as legal, regulatory, compliance, cybersecurity, financial, or professional advice. Healthcare organizations should consult their legal counsel, compliance officers, privacy and security professionals, and other qualified advisors before making decisions regarding AI technologies, HIPAA compliance, data security, or patient information management.
Artificial intelligence has entered healthcare with a promise that is hard to ignore: faster workflows, fewer manual tasks, lower costs, better coordination, and fewer errors. For practices and healthcare organizations under pressure to do more with less, that promise can sound very attractive.
The market has noticed. New tools appear constantly, many with polished graphics, confident claims, and familiar buzzwords. Some are genuinely useful. Others solve narrow problems while creating new legal, security, operational, or insurance exposure.
The practical question is not whether AI belongs in healthcare. It does. The better question is whether a specific vendor is ready to touch your workflows, your systems, and potentially your protected health information.
Buying AI in Healthcare requires the same discipline used for any other high-risk operational decision. Large health systems usually put these tools through IT, legal, compliance, privacy, security, finance, and operations review before anything goes live. Smaller practices may not have those departments, but they still need a scaled version of that process.
It is easy to sign up for a platform. It is much harder to unwind a poor vendor decision after a data incident, contract dispute, workflow failure, or patient complaint.
Start with the risk, not the demo
A vendor demo is designed to show the best version of the product. That is not a criticism. It is simply how demos work.
The review process should begin somewhere else. Start with the risk created by the tool.
Ask what the system will actually do inside the organization. Will it read patient records? Draft clinical notes? Process claims data? Connect to scheduling, billing, imaging, pharmacy, or lab systems? Send messages to patients? Summarize phone calls? Recommend workflow actions?
Each use case carries a different risk profile. A tool that organizes internal task lists is not the same as a tool that ingests clinical documentation or handles patient communications. A platform that never touches protected health information is different from one that stores, analyzes, or transmits HIPAA-sensitive data.
Before evaluating the features, define the exposure.
A basic intake should answer:
What data will the vendor access?
What systems will it connect to?
Where will the data be processed?
Where will the data be stored?
Who can access the data at the vendor?
How long is data retained?
Can the vendor use the data to train its models?
What happens when the contract ends?
If the vendor cannot clearly answer these questions, the review should slow down. AI may feel new, but the fundamentals of third-party risk management still apply.
HIPAA review is not optional
Any vendor that creates, receives, maintains, or transmits protected health information on behalf of a covered entity or business associate needs careful HIPAA review. That usually means a business associate agreement, but the agreement alone is not the full review.
A signed document does not prove the vendor has sound security practices. It does not prove the system was built for healthcare. It does not prove your practice can recover if something goes wrong.
The review should cover both contract language and operational controls.
Key areas include:
Whether the vendor will sign an appropriate business associate agreement
Whether the agreement clearly defines permitted uses of data
Whether the vendor can use de-identified or aggregated data
Whether subcontractors are involved
Whether offshore access or processing is part of the service
Whether breach notification timelines are clear
Whether audit rights or security documentation are available
Whether data return and deletion terms are practical
Pay close attention to model training language. Some AI vendors reserve broad rights to use customer data to improve their products. In healthcare, that needs careful review. Even when data is described as de-identified, the organization should understand the process, the safeguards, and the residual risk.
This is also where legal counsel and compliance input matter. A short review at the front end can prevent a much larger problem later.
The right question is not, “Can this tool help us?” The right question is, “Can this tool help us safely, lawfully, and reliably?”
Security claims need evidence
Many vendors say their platform is secure. That statement has little value by itself.
A security review should look for evidence that matches the risk of the tool. The more sensitive the data and the deeper the system integration, the more evidence the vendor should provide.
At a practical level, an organization should ask for security documentation that explains:
Encryption during transmission and storage
Access controls and user permissions
Multi-factor authentication options
Logging and monitoring
Incident response process
Data backup and recovery
Vulnerability management
Subcontractor controls
Data segregation between customers
Retention and deletion procedures
The goal is not to turn practice administrators into cybersecurity engineers. The goal is to recognize when outside expertise is needed.
If a private practice does not have the technical expertise to evaluate a third-party system, it should bring in help. That may be an IT consultant, cybersecurity advisor, healthcare attorney, compliance consultant, or insurance advisor. The cost of review should be part of the buying decision, not treated as an obstacle.
AI tools often connect to systems that contain sensitive operational and clinical data. A weak integration can create exposure even if the main platform looks polished.
Security review should also include how data moves. Does the product use secure APIs? Are files uploaded manually? Does staff copy and paste patient information into the tool? Does the platform send data to external services? Are access logs available if an incident occurs?
These details are not minor. They define the real risk.
Insurance should be part of the conversation
AI vendor review often focuses on features, price, and security. Insurance sometimes comes too late.
That is a mistake.
If a vendor will handle protected health information, the contract should address insurance coverage. The organization also needs to review its own policies. Cyber liability, technology errors and omissions, professional liability, and general liability may all become relevant depending on the use case.
The practical questions include:
Where is your vendor located, and under whose jurisdiction do they operate? When patient data is involved, understanding your legal and operational recourse before an incident occurs is part of responsible vendor selection.
Does the vendor carry cyber liability coverage?
Does the vendor carry errors and omissions coverage?
Are coverage limits appropriate for the risk?
Are HIPAA-related claims included or excluded?
Are subcontractors covered?
Is the organization named as an additional insured where appropriate?
Does the contract include indemnification, and is it meaningful?
Does your own carrier know about this vendor or use case?
That last question matters. Some policies may have notice requirements, exclusions, or underwriting expectations tied to new technology, data handling, or third-party vendors. If an organization adopts a tool that materially changes its risk profile, the insurance carrier should not learn about it for the first time after a claim.
This is informational only and not legal, insurance, or financial advice. Specific coverage questions should be reviewed with qualified advisors and the organization’s insurance professionals.
Do not confuse automation with accountability
A good AI tool can reduce repetitive administrative work. It may help sort documents, summarize information, flag missing fields, draft routine messages, or support healthcare automation in scheduling, billing, coding support, and intake workflows.
Those uses can be valuable. They can save time and reduce staff frustration.
Still, automation does not remove accountability. The healthcare organization remains responsible for how the tool is used.
That means policies and workflows need to define:
Who reviews AI-generated output
What staff may enter into the tool
What use cases are prohibited
When human review is required
How errors are reported
How patient complaints are handled
How the tool is monitored over time
This is especially important when AI output appears confident. Staff may trust a clean summary, a suggested response, or a prefilled field because it looks complete. The system may still miss context, misunderstand information, or fail when the input is unusual.
AI should not be treated as a silent staff member with unlimited discretion. It should be treated as a tool with defined boundaries.
Test real work, not just the easy cases
Many products perform well on low-friction examples. The real test is whether the tool handles the messy work that consumes staff time.
Before buying, build a test set of actual use cases. Do not use live patient information unless the proper agreements and safeguards are already in place. Use de-identified, synthetic, or appropriately approved test data when possible.
The test should include routine cases and edge cases.
Routine cases might include:
Standard intake forms
Common referral documents
Typical prior authorization packets
Straightforward appointment requests
Clean billing support examples
Edge cases should be more challenging:
Incomplete forms
Conflicting information
Duplicate records
Unusual payer rules
Patient messages with unclear intent
Multiple conditions in one note
Poorly formatted scanned documents
Data that should not be acted on without review
This step often reveals the real value of the product. A tool may handle the easy work but fail on the exceptions that drive labor cost. If staff must spend time finding and correcting errors, the business case may change.
The review should ask:
How often does the tool require human correction?
How long does review take?
What errors are most common?
Are errors easy to detect?
Can the workflow prevent bad output from reaching patients, payers, or records?
What level of staff training is needed?
How much vendor support is required after launch?
A platform can still be worth buying if it needs oversight. Most tools do. The key is to count that oversight honestly.
Build the full cost into the decision
The subscription price is only one part of the cost.
A proper cost analysis should include implementation, training, integration, compliance review, security review, legal review, insurance review, staff oversight, workflow redesign, and ongoing monitoring.
For smaller practices, those costs may feel heavy. Yet they are part of responsible adoption. A low monthly fee can become expensive if the product creates rework, requires constant supervision, or introduces risk that was not priced into the decision.
The business case should include both savings and new labor.
For example, if an AI tool reduces intake processing time but requires a staff member to audit every output, the net savings may still be positive. Or they may disappear. If the tool helps with prior authorization but fails on complex cases, the practice needs to know whether those complex cases were the reason it needed help in the first place.
A practical cost review should compare:
Expected benefit
New internal work
One-time costs
Ongoing costs
Faster task completion, fewer repetitive steps, improved staff capacity
Review time, exception handling, error correction, training, monitoring
Legal review, IT setup, integration, policy updates, staff training
Subscription fees, vendor support, audits, insurance adjustments, compliance oversight
A good vendor should welcome this analysis. If the product has real value, it should hold up under practical scrutiny.
Use a scaled version of a health system review
Large health systems often use formal vendor review committees. They may involve IT security, privacy, legal, compliance, procurement, finance, clinical leadership, operations, and risk management.
A private practice does not need the same machinery. It does need the same categories of review at the right scale.
A lean process can still be disciplined:
Define the use case
Be specific about what problem the tool will solve and what it will not do.
Map the data
Identify every type of data the vendor will access, process, store, or transmit.
Review HIPAA and contracts
Confirm business associate terms, data use rights, breach obligations, and termination procedures.
Check security
Have qualified personnel review security controls, integrations, access, and data flow.
Review insurance
Confirm vendor coverage and discuss the use case with your own insurance professionals.
Test the workflow
Run routine cases and edge cases before relying on the tool in production.
Train staff
Set boundaries around use, review, escalation, and prohibited data entry.
Monitor after launch
Track errors, time savings, staff burden, patient complaints, and vendor performance.
This is not bureaucracy for its own sake. It is how healthcare organizations protect patients, staff, data, and the business.
Vendor answers should be clear and consistent
During review, watch how the vendor responds to detailed questions. The quality of the response often tells you as much as the answer itself.
Strong vendors tend to be clear about what they do, what they do not do, and where human review is still needed. They can explain their security approach without hiding behind vague claims. They understand healthcare contracting. They can provide documentation without treating every request as unusual.
Be cautious with vendors that:
Avoid direct answers about data use
Refuse reasonable contract terms
Cannot explain where data is housed
Treat HIPAA questions as a formality
Push for rapid signup before review
Promise broad results without workflow details
Minimize the need for staff oversight
Cannot support implementation at your scale
A polished product page does not replace operational readiness. The vendor relationship will matter long after the first login.
Good AI purchases are slow enough to be safe
There are worthwhile AI tools in healthcare. Some can reduce repetitive administrative work, support staff, improve handoffs, and make daily operations less difficult. Dismissing all AI would be as shortsighted as buying every tool that sounds impressive.
The right posture is careful interest.
AI vendors should be evaluated with the same seriousness as any system that touches protected health information, revenue cycle workflows, patient communications, or clinical operations. That means security review, HIPAA review, contract review, insurance review, workflow testing, and ongoing monitoring.
The organizations that benefit most will not be the ones that buy the fastest. They will be the ones that define the problem clearly, test the tool honestly, and understand the risk before the system goes live.
Take the time to do the diligence at your scale. A careful review may delay implementation by a few weeks. That is a small price compared with the cost of a tool that fails when the stakes are high.
Disclaimer: The information provided in this article is for educational and informational purposes only and reflects considerations that healthcare organizations may wish to evaluate when assessing AI solutions. It is not intended to constitute legal, regulatory, cybersecurity, HIPAA, or compliance advice. Organizations should consult qualified legal counsel, compliance professionals, privacy officers, and security experts when evaluating AI technologies and their specific regulatory obligations.
Comments